Inventor
Yibin Zeng
Inventor
Foster City, CA, US
Overview
Patents· 45 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry5%
C07CAcyclic or carbocyclic compounds3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07KPeptides1%
PatentTitleYear
11,059,825CXCR7 antagonists202111,026,935Free base crystalline form of a complement component C5a receptor202111,020,394Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C--C chemokine receptor type 9 (CCR9) and anti-a4b7 integrin blocking antibodies202110,899,765Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation202110,828,285Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors202010,759,807Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors202010,683,2945-5 fused rings as C5a inhibitors202010,660,897C5aR antagonists202010,596,163Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides202010,562,8966-5 fused rings as C5a inhibitors202010,532,044Heteroaryl sulfonamides and CCR2/CCR9202010,532,051Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-a4b7 integrin blocking antibodies202010,487,098Soluble C5aR antagonists201910,464,934Substituted tetrahydropyrans as CCR2 modulators201910,329,314Soluble C5aR antagonists201910,287,292CXCR7 antagonists201910,206,912Heteroaryl sulfonamides and CCR2/CCR9201910,208,050Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation201910,137,120Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides201810,035,768C5aR antagonists20189,783,544'CXCR7 antagonists'20179,783,540'Substituted tetrahydropyrans as CCR2 modulators'20179,745,312'Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation'20179,573,897'C5AR antagonists'20179,394,307'Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation'20169,296,740'Azaindazole compounds and methods of use'20169,169,261'CXCR7 antagonists'20159,126,939'C5AR antagonists'20158,946,240'4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines'20158,916,601'Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides'20148,906,938'C5aR antagonists'20148,853,202'Modulators of CXCR7'20148,546,408'Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation'20138,481,579'Triazolyl phenyl benzenesulfonamides'20138,445,518'Triazolyl pyridyl benzenesulfonamides'20138,445,515'C5aR antagonists'20138,343,975'4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines'20138,288,373'Modulators of CXCR7'20128,153,818'Triazolyl phenyl benzenesulfonamides'20128,093,247'Heteroaryl sulfonamides and CCR2'20127,884,110'Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation'20117,777,035'Azaindazole compounds and methods of use'20107,718,683'Triazolyl phenyl benzenesulfonamides'20107,683,176'Triazolyl pyridyl benzenesulfonamides'20107,622,583'Heteroaryl sulfonamides and CCR2'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2021Patents assigned to CHEMOCENTRYX INC (43)· patent assignee history
2009–2021Based in San Mateo, CA, US· patent location history
2012–2015Patents assigned to ZENG YIBIN (10)· patent assignee history
2012–2013Patents assigned to PUNNA SREENIVAS (5)· patent assignee history
2012–2013Patents assigned to UNGASHE SOLOMON (5)· patent assignee history
2012–2013Patents assigned to CHARVAT TREVOR T (4)· patent assignee history
2012–2021Based in Foster City, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHEMOCENTRYX INC | 43 | 2009–2021 |
| ZENG YIBINself | 10 | 2012–2015 |
| PUNNA SREENIVAS | 5 | 2012–2013 |
| UNGASHE SOLOMON | 5 | 2012–2013 |
| CHARVAT TREVOR T | 4 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Foster City, California, US | 28 | 2012–2021 |
| San Mateo, California, US | 17 | 2009–2021 |